Target intelligence / Profile preview

Ribosomal protein SA pseudogene 7 (RPSAP7)

Target
RPSAP7
Molecular classification
Other (pseudogene; not a receptor, enzyme, transporter, or classic protein class)
01

Overview

Ribosomal protein SA pseudogene 7 (RPSAP7) is a processed pseudogene of the functional ribosomal protein SA (RPSA) gene, sharing nearly identical sequence and open reading frame, except for a single amino acid change[1][5]. Like other pseudogenes, RPSAP7 does not code for a functional protein in humans and is not believed to be transcribed or translated into a biologically active form under normal circumstances. While pseudogenes can occasionally produce regulatory RNA or rare proteins in some contexts, there is no robust evidence for such a role for RPSAP7. The functional RPSA protein itself is involved in ribosomal structure, cell adhesion (as a laminin receptor), and pathologies such as cancer and prion diseases, but these activities do not pertain to RPSAP7[7][1]. Pseudogenes in general may modulate their parental gene's expression by acting as microRNA decoys or source of regulatory non-coding RNAs, but RPSAP7 has not been shown to directly participate in such mechanisms[6]. In summary, RPSAP7 is a non-coding genetic element and is not classified as a therapeutic target, receptor, enzyme, transporter, or biomarker. It does not have any established protein function, disease role, or pharmacological relevance.

Other names
Laminin receptor 1 pseudogene 7LAMR1P7RPSA_16_1024RPSAP7
02

Biological functions

Other (some pseudogenes may have regulatory non-coding RNA function, but classic protein functions such as signal transduction, cell cycle, etc., are not established for RPSAP7)
03

Disease associations

Other

Beyond the preview

Go deeper on Ribosomal protein SA pseudogene 7 (RPSAP7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein SA pseudogene 7 (RPSAP7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call